Restorbio Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Restorbio Inc
TickerACET
CIK #0001720580
CUSIP004446100
SectorLife Sciences - Pharmaceutical Preparations
Address500 Boylston Street 12th Floor, Boston, MA 02116
Source [EDGAR]
CIK Filing 2011 - 2026
[0001720580] 10-K
[0001720580] 10-Q
[0001720580] 3
[0001720580] 4
[0001720580] 5
[0001720580] 8-K
[0001720580] SC 13D
[0001720580] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Woodline Partners LP Adicet Bio Inc [2026-02-17] 0.0
Franklin Resources Inc Adicet Bio Inc [2026-01-29] 0.0
Millennium Management LLC Adicet Bio Inc [2024-02-27] 5.2
Morgan Stanley Adicet Bio Inc [2024-02-12] 6.4
RA Capital Management LP Adicet Bio Inc [2024-02-05] 0.99
Commodore Capital LP Adicet Bio Inc [2024-01-19] 0.8
Tang Capital Partners LP Adicet Bio Inc [2023-03-13] 5.3
BlackRock Inc Adicet Bio Inc [2023-02-13] 5.9
State Street Corp Adicet Bio Inc [2023-02-03] 5.33
EcoR1 Capital LLC Adicet Bio Inc [2022-12-23] 8.3
RA Capital Management LP Adicet Bio Inc [2022-10-17] 5.5
Cowen Financial Products LLC Adicet Bio Inc [2022-04-22] 7.46
RTW Investments LP Adicet Bio Inc [2021-12-15] 7.91
Abingworth LLP Adicet Bio Inc [2021-03-08] 5.2
Abingworth LLP Adicet Bio Inc [2021-03-08] 5.2
Avidity Partners Management LP Adicet Bio Inc [2021-02-12] 0.5
Schindel Yair Chaim Adicet Bio Inc [2020-09-24] 5.7
Adicet Bio Inc Restorbio Inc [2020-05-08] 25.07
Morgan Stanley Restorbio Inc [2019-12-30] 8.8
Armistice Capital LLC Restorbio Inc [2019-12-19] 0.6
Invesco Ltd Restorbio Inc [2019-06-10] 12.1
OppenheimerFunds Inc Restorbio Inc [2019-04-10] 12.24
Jennison Associates LLC Restorbio Inc [2019-02-01] 7.6
Prudential Financial Inc Restorbio Inc [2019-01-28] 7.6
FMR LLC Restorbio Inc [2018-03-12] 0.0
Novartis AG Restorbio Inc [2018-02-14] 7.2
Puretech Health LLC Restorbio Inc [2018-02-09] 34.94
OrbiMed Advisors LLC Restorbio Inc [2018-02-02] 17.22
Form 3/4/5 Filer 2011 - 2026
Dubin Steve
Adicet Bio Inc
Grissinger Michael
Chodakewitz Jeffrey
Schor Chen
Peng Katie
Aftab Blake
Klickstein Lloyd
Sinclair Andrew
Shah Rajeev M
Kolchinsky Peter
RA Capital Management LP
RA Capital Healthcare Fund LP
OrbiMed Genesis GP LLC
OrbiMed Capital GP V LLC
OrbiMed Israel GP II LP
OrbiMed Israel BioFund GP Limited Partnership
OrbiMed Capital GP VI LLC
OrbiMed Advisors LLC
OrbiMed Advisors Israel II Ltd
OrbiMed Israel GP Ltd
Harvey Brian Nicholas
Healey Don
Maltzman Julia D
Gordon Carl L
Jakobovits Aya
Kauffman Michael
Galimi Francesco
Sanna Bastiano
Chimovits Erez
Abbot Stewart
Krehlik Carrie
Schindel Yair Chaim
Steinberg David Adam
Sullivan Lynne Marie
Silverstein Jonathan
Fonteyne Paul R
PureTech Health LLC
Mannick Joan
McCabe John J
Manning Meredith
Zohar Daphne
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Healey Don
Stock Option (Right to Buy) · derivative
2026-03-25 Grant 43,361 $0.00
Schor Chen
Stock Option (Right to Buy) · derivative
2026-03-25 Grant 468,555 $0.00
Aftab Blake
Stock Option (Right to Buy) · derivative
2026-03-25 Grant 72,555 $0.00
Harvey Brian Nicholas
Stock Option (Right to Buy) · derivative
2026-03-25 Grant 43,361 $0.00
Maltzman Julia D
Stock Option (Right to Buy) · derivative
2026-03-25 Grant 72,555 $0.00
Harvey Brian Nicholas
Common Stock
2026-01-24 Tax withheld 546 $8.44 4,608
Healey Don
Common Stock
2026-01-24 Tax withheld 535 $8.44 4,515
Schor Chen
Common Stock
2026-01-24 Tax withheld 1,755 $8.44 14,812
Aftab Blake
Common Stock
2026-01-24 Tax withheld 535 $8.44 4,515
OrbiMed Genesis GP LLC +7
Common Stock
2025-10-08 Buy 1,500,000 $1.00 1,500,000
OrbiMed Genesis GP LLC +7
Common Stock
2025-10-08 Buy 3,500,000 $1.00 3,500,000
Dubin Steve
Stock Option (Right to Buy) · derivative
2025-06-11 Grant 26,400 $0.00
Chodakewitz Jeffrey
Common Stock
2025-06-11 Grant 5,900 $0.00
Peng Katie
Stock Option (Right to Buy) · derivative
2025-06-11 Grant 26,400 $0.00
Klickstein Lloyd
Common Stock
2025-06-11 Grant 5,900 $0.00
Dubin Steve
Common Stock
2025-06-11 Grant 5,900 $0.00
Sinclair Andrew
Stock Option (Right to Buy) · derivative
2025-06-11 Grant 26,400 $0.00
Klickstein Lloyd
Stock Option (Right to Buy) · derivative
2025-06-11 Grant 26,400 $0.00
Peng Katie
Common Stock
2025-06-11 Grant 5,900 $0.00
Chodakewitz Jeffrey
Stock Option (Right to Buy) · derivative
2025-06-11 Grant 26,400 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 50 6,459,878
2025-12-31 49 6,753,722
2025-09-30 54 51,402,772
2025-06-30 50 51,631,031
2025-03-31 57 55,909,435
2024-12-31 65 57,663,593
2024-09-30 65 55,339,921
2024-06-30 87 64,005,355
2024-03-31 99 83,379,443
2023-12-31 78 36,205,310
2023-09-30 85 35,699,266
2023-06-30 96 37,200,413
Form 13F Holdings
Firm Period DFND Voting Shares
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com